Full Text View
Tabular View
No Study Results Posted
Related Studies
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
This study has been completed.
Study NCT00521859   Information provided by M.D. Anderson Cancer Center

First Received on August 27, 2007.   Last Updated on July 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hematologic Malignancies
Additional conditions recognized in this trial
Hematologic Neoplasms
Neoplasms
More general conditions related to this trial
Hematologic Diseases
Neoplasms by Site
Interventions listed in this trial
Cloretazine
Fludarabine
Additional drug interventions recognized in this trial
Fludarabine monophosphate
Vidarabine
More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Vion Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services